Strides Agrees on Injectables Deal

Pharmaceutical company Strides Arcolab (Bangalore, India) says it has agreed on a deal with pharma manufacturer Sagent Pharmaceuticals (Schaumburg, IL) to jointly develop, supply, and market injectable products for the U.S. market. Strides Arcolab will develop and supply injectable products that Sagent will market in the U.S., under terms of the deal. The agreement will initially target 25 products, the companies say. Sagent is a privately held specialty pharma company that was founded in 2006. “The strength and experience of our sales organization as well...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers